2m 2m 2m 2m 2m 2m 2m
SUTRO BIOPHARMA (STRO)
NASDAQ
$16.20-$0.66 (-3.91%)
Price as of Sep 11, 2026 7:55 PM EDT- $279.6MMarket Cap
- 92.27%1-Year Change
- BiotechnologyIndustry
SUTRO BIOPHARMA (STRO)
$16.20-$0.66 (-3.91%)
STRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.86 | ||
Change | -$0.97 (-5.44%) | ||
Open | $18.07 | ||
High | $18.27 | ||
Low | $16.48 | ||
Previous Close | $17.83 | ||
Volume | 942,335 | ||
30-Day Average Volume | 307,048 | ||
1-Week Change | -15.99% | ||
1-Month Change | -32.67% | ||
1-Year Change | 92.27% | ||
3-Year Change | -63.35% | ||
5-Year Change | -91.52% | ||
Fundamentals | |||
Shares Outstanding | 16.6M | ||
Total Assets | $194.5M | ||
Market Cap | $279.6M | ||
Enterprise Value | $225.2M | ||
Period: QTR TTM FY | |||
Revenue | $9.8M | ||
Net Income | -$38.5M | ||
Free Cash Flow | -$38.3M | ||
EBIT | -$38.5M | ||
EBITDA | -$37.3M | ||
Net Working Capital | $122.7M | ||
EPS | -$2.33 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 23 | ||
P/B | -3 | ||
P/E | -7 | ||
PEG | -0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 12/03/2025 | ||
Earnings & Revenue